in

Biopharmaceutical company: NovaBay Pharmaceuticals, Inc. (NBY)

NovaBay Pharmaceuticals, Inc. (NASDAQ:NBY) was founded in 2000, formerly known as NovaCal Pharmaceuticals, Inc., and changed to its current name in February 2007. Headquartered in Emeryville, California, with 70 full-time employees, it is a biopharmaceutical company , Develop, manufacture and sell ophthalmic non-antibiotic and anti-infective products in the United States, China and internationally.

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc. (NBY):

NovaBay Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company located in Emeryville, California, founded by organic chemist Ron Najafi, who has worked in several pharmaceutical, chemical and biotechnology companies in the United States. Najafi is interested in HOCl, hypochlorous acid, and antibacterial substances produced by white blood cells, as well as studying the chemical reactions of white blood cells in the oxidative burst cycle. HOCl and other chlorine-containing chemicals can resist invading microorganisms.

Najafi founded NovaBay Pharmaceuticals in 2000 to create a stable version of HOCl.

NovaBay Pharmaceuticals focuses on the development of new, fast-acting, synthetic anti-infective compounds. These compounds are designed to mimic the body’s defense system against infection. The company currently focuses on products for the eye care market, including:

Avenova, a prescription product that cleans and removes foreign substances, including microbes and debris from the skin around the eyes; NeutroPhase, for the wound care market; CelleRx, for the cosmetic dermatology market; Aganocide compound patented synthetic molecule, used to combat Bacteria, viruses and fungi; auriclosene lavage solution for urology; intelli-Case, a device for soft and rigid breathable contact lenses.

NovaBay Pharmaceuticals signed a cooperation and licensing agreement with Virbac to develop auriclosene, a proprietary compound for the veterinary market.

Stock price changes:

On June 10, 2019, NovaBay Pharmaceuticals Inc.’s stock price soared by 770%, as the biopharmaceutical company said its Avenova eye care products are now available on Amazon without a prescription through its new direct-to-consumer online channel .

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all Intels

Well-known American steel plate and steel structure manufacturer: Steel Dynamics (STLD) (1993)

Oil and gas pipeline company: DCP Midstream, LP(DCP) (2005)